Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11864-022-00992-y | DOI Listing |
HCA Healthc J Med
December 2024
Heritage Valley Health System, Beaver Falls, PA.
Background: Second-generation antipsychotic medications (SGAs) are often used by primary care physicians (PCPs) to treat multiple psychiatric diagnoses. SGAs have been connected to a number of adverse effects, including cardiovascular disease. Currently, there are no published evidence-based recommendations addressing SGAs and cardiotoxicity that are directed toward PCPs.
View Article and Find Full Text PDFBr J Cancer
January 2025
Department of Radiation Oncology, Washington University in St Louis, Saint Louis, MO, USA.
Biomedicines
December 2024
Department of Pediatrics, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Background And Objectives: Anthracycline chemotherapy is a cornerstone in pediatric oncology but carries a significant risk of cardiotoxicity. The early detection of cardiac dysfunction is crucial for timely intervention. This study aims to evaluate the predictive value of combining speckle tracking echocardiography (STE) parameters with traditional cardiac biomarkers for the early detection of anthracycline-induced cardiotoxicity in pediatric oncology patients.
View Article and Find Full Text PDFMol Cell Biochem
November 2024
Department of Cardiology, Fujian Medical University Union Hospital, Fujian Cardiovascular Medical Center, Fujian Institute of Coronary Artery Disease, Fujian Cardiovascular Research Center, Fuzhou, 350001, People's Republic of China.
Cureus
September 2024
Anesthesiology, Shri B M Patil Medical College Hospital and Research Centre, Bijapur Liberal District Educational (BLDE) University, Vijayapura, IND.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!